Showing 7,381 - 7,400 results of 31,172 for search '(( 2 step decrease ) OR ( 50 ((((we decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 0.81s Refine Results
  1. 7381

    Comparative experimental results. by Chunming Wen (17616274)

    Published 2025
    “…The experimental results show that the model before pruning has 96.1% and 53.2% mean average precision mAP50 and mAP50:95, respectively, which are 11.9% and 11.1% higher than the original YOLO11n, and the model after pruning also has 10.8% and 9.3% higher than the original YOLO11n, respectively, and the number of parameters is reduced to 279,778, and model size is reduced to 1.3MB. …”
  2. 7382
  3. 7383
  4. 7384
  5. 7385
  6. 7386
  7. 7387
  8. 7388

    Image_2_PIK3CA-Related Overgrowth Spectrum From Diagnosis to Targeted Therapy: A Case of CLOVES Syndrome Treated With Alpelisib.JPEG by Angelica Pagliazzi (11413274)

    Published 2021
    “…We noticed a decrease in fibroadipose overgrowth at the dorsal level, an improvement in in posture and excellent tolerability. …”
  9. 7389

    table3_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  10. 7390

    table1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  11. 7391

    image1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  12. 7392

    table5_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  13. 7393

    table4_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  14. 7394
  15. 7395

    Data Sheet 2_Screening of neurotransmitter receptor modulators reveals novel inhibitors of influenza virus replication.pdf by Yarou Gao (20620991)

    Published 2025
    “…We identified 20 candidate compounds with IC50 values below 20 μM, suggesting a critical role for these receptors in influenza replication. …”
  16. 7396
  17. 7397

    Preventing Protein Oxidation with Sugars: Scavenging of Hypohalous Acids by 5‑Selenopyranose and 4‑Selenofuranose Derivatives by Corin Storkey (1820602)

    Published 2012
    “…Reaction with HOSCN is slower (∼10<sup>2</sup> M<sup>–1</sup> s<sup>–1</sup>). The seleno-sugars decreased the extent of HOCl-mediated oxidation of Met, His, Trp, Lys, and Tyr residues, and 3-chlorotyrosine formation, on both isolated bovine serum albumin and human plasma proteins, at concentrations as low as 50 μM. …”
  18. 7398

    Exposure to Contemporary and Emerging Chemicals in Commerce among Pregnant Women in the United States: The Environmental influences on Child Health Outcome (ECHO) Program by Jessie P. Buckley (12525195)

    Published 2022
    “…Among our diverse prenatal population (60% non-Hispanic Black or Hispanic), we detected 73 of 89 analytes in ≥1 participant and 36 in >50% of participants. …”
  19. 7399
  20. 7400